RNA, U6 small nuclear 1116, pseudogene (RNU6-1116P)

RNU6-1116P, or "RNA, U6 small nuclear 1116, pseudogene," designates a specific **pseudogene** related to the highly conserved U6 small nuclear RNA (snRNA)[3]. The parent U6 snRNA is a critical component of the spliceosome, involved in the removal of introns from pre-mRNA during mRNA processing in eukaryotic cells[1][3]. U6 snRNA genes and their pseudogenes are present in multiple copies across the vertebrate genome, reflecting the evolutionary importance of the U6 RNA[3]. Pseudogenes like RNU6-1116P are generally thought to be transcriptionally inactive, lacking the ability to encode functional RNA or protein products, though some pseudogenes have been implicated in gene regulation at the RNA level in certain contexts by acting as sources of regulatory RNAs or by serving as decoys for transcriptional or post-transcriptional regulators[2][4]. However, there is no direct evidence for any such function for RNU6-1116P itself, nor is it identified as a disease gene, therapeutic target, or biomarker in current literature[2][4]. In summary, RNU6-1116P is a named human pseudogene of U6 snRNA, not a therapeutic target, not known to have direct biological or disease roles, and is not actionable in drug development or clinical diagnostics at this time[2][3][4].

Other names

RNU6-1116PRNA, U6 small nuclear 1116, pseudogene

Not applicable (no known drugs or direct modulators)